Home › Linfoma di Burkitt › Missouri › Kansas City
Studi clinici su Linfoma di Burkitt a Kansas City, MO
10 studi su Linfoma di Burkitt cercano partecipanti presso sedi a Kansas City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
In reclutamentoFase 2
- Children's Mercy Hospitals and Clinics, Kansas City
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
In reclutamentoFase 3
- University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi di distanza
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
In reclutamentoFase 2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi di distanza
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
In reclutamentoFase 2
- Children's Mercy Hospitals and Clinics, Kansas City
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
In reclutamentoFase 1/2
- Children's Mercy Hospital ( Site 1024), Kansas City
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
In reclutamentoFase 2
- Children's Mercy Hospitals and Clinics, Kansas City
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
In reclutamentoFase 3
- Children's Mercy Hospitals and Clinics, Kansas City
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
In reclutamentoFase 1/2
- University of Kansas Hospital-Westwood Cancer Center, Westwood · a 5 mi di distanza
Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies
In reclutamentoFase 1
- University of Kansas Cancer Center, Westwood · a 5 mi di distanza
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
In reclutamentoFase 2
- Children's Mercy Hospital, Kansas City
Studi su Linfoma di Burkitt in altre città
- Houston, TX21 studi
- Philadelphia, PA16 studi
- Milwaukee, WI16 studi
- Chicago, IL15 studi
- New York City, NY13 studi
- Cincinnati, OH13 studi
- Atlanta, GA12 studi
- Aurora, CO11 studi
- Seattle, WA11 studi
- Durham, NC10 studi
- Boston, MA10 studi
- Los Angeles, CA10 studi
Altri studi a Kansas City
- Cancro al seno34 studi
- Cancro del polmone non a piccole cellule31 studi
- Insufficienza cardiaca25 studi
- Cancro (tutti i tipi)21 studi
- Cancro ai polmoni19 studi
- Cancro colorettale16 studi
- Cancro metastatico15 studi
- Leucemia mieloide acuta15 studi
- Cancro alla prostata14 studi
- Cancro ovarico11 studi
- Obesità11 studi
- Diabete di tipo 211 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.